The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Verrica Pharmaceuticals Inc (NASDAQ: VRCA) closed at $0.64 in the last session, down -1.39% from day before closing price of $0.65. In other words, the price has decreased by -$1.39 from its previous closing price. On the day, 0.55 million shares were traded.
Ratios:
We take a closer look at VRCA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.22 and its Current Ratio is at 1.34.
Needham Upgraded its Hold to Buy on July 25, 2023, while the target price for the stock was maintained at $10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 26 ’24 when Hayes Christopher G. sold 26,183 shares for $2.66 per share. The transaction valued at 69,647 led to the insider holds 115,303 shares of the business.
Hayes Christopher G. sold 9,530 shares of VRCA for $23,444 on Aug 27 ’24. The CHIEF LEGAL OFFICER now owns 105,773 shares after completing the transaction at $2.46 per share. On Aug 26 ’24, another insider, Goldenberg Gary, who serves as the Chief Medical Officer of the company, sold 9,888 shares for $2.66 each. As a result, the insider received 26,302 and left with 97,862 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 6.29.
Stock Price History:
Over the past 52 weeks, VRCA has reached a high of $11.41, while it has fallen to a 52-week low of $0.59. The 50-Day Moving Average of the stock is -6.71%, while the 200-Day Moving Average is calculated to be -80.36%.
Shares Statistics:
A total of 90.56M shares are outstanding, with a floating share count of 49.03M. Insiders hold about 45.86% of the company’s shares, while institutions hold 33.10% stake in the company.
